ACADIA Pharmaceuticals Inc.
Status: Publicly traded
Direct answer
ACADIA Pharmaceuticals Inc. is publicly traded on NASDAQ under the ticker ACAD.
ACADIA Pharmaceuticals Inc. operates as a biopharmaceutical company, primarily dedicated to discovering, developing, and commercializing small molecule therapeutics. Their core focus lies in addressing critical unmet medical needs within the realm of central nervous system (CNS) disorders. The company's marketed product, NUPLAZID (pimavanserin), is prescribed for the management of hallucinations and delusions...
Can you invest in ACADIA Pharmaceuticals Inc.?
Yes. ACADIA Pharmaceuticals Inc. is publicly traded on NASDAQ under the ticker ACAD.
View deeper analysis
View detailed research on MarketSnap, including financials, valuation tools, and analyst context.
Open research for ACADIA Pharmaceuticals Inc.
Detailed equity research is provided by MarketSnap.